Literature DB >> 34521610

Employing competing risks analysis in an aging population where many patients die from other causes.

Jessica R Flynn1, Edmund K Bartlett2, Stuart M Lichtman3, Katherine S Panageas4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34521610      PMCID： PMC8882124          DOI： 10.1016/j.jgo.2021.09.002

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  9 in total

Review 1.  The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study.

Authors:  Sally R Hinchliffe; Keith R Abrams; Paul C Lambert
Journal:  Cancer Epidemiol       Date:  2012-09-20       Impact factor: 2.984

2.  Competing risks survival of older patients with metastatic cutaneous melanoma: a SEER population-based study.

Authors:  Jessica R Hoag; Upendra Hegde; Rebecca Zweifler; Marianne Berwick; Helen Swede
Journal:  Melanoma Res       Date:  2016-10       Impact factor: 3.599

3.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

4.  Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials.

Authors:  Nikki Burdett; Andrew D Vincent; Michael O'Callaghan; Ganessan Kichenadasse
Journal:  J Natl Cancer Inst       Date:  2018-08-01       Impact factor: 13.506

5.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

6.  Introduction to the Analysis of Survival Data in the Presence of Competing Risks.

Authors:  Peter C Austin; Douglas S Lee; Jason P Fine
Journal:  Circulation       Date:  2016-02-09       Impact factor: 29.690

7.  Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.

Authors:  Weidong Shen; Naoko Sakamoto; Limin Yang
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

Review 8.  A note on competing risks in survival data analysis.

Authors:  J M Satagopan; L Ben-Porat; M Berwick; M Robson; D Kutler; A D Auerbach
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

9.  Competing risks and cancer-specific mortality: why it matters.

Authors:  Kay See Tan; Takashi Eguchi; Prasad S Adusumilli
Journal:  Oncotarget       Date:  2017-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.